Savara IncNASDAQ:SVRA
- LAST PRICE4.0200
- TODAY'S CHANGE (%)0.1300 (3.3419%)
- Bid / Lots3.9000/ 2
- Ask / Lots4.0500/ 4
- Open / Previous Close3.8800 / 3.8900
- Day Range
- 52 Week Range
- Volume2,802,753
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SVRA |
|---|---|---|
| 09:32 ET | 1739 | 3.88 |
| 09:35 ET | 200 | 3.88 |
| 09:39 ET | 1028 | 3.86 |
| 09:42 ET | 1036 | 3.86 |
| 09:44 ET | 400 | 3.85 |
| 09:46 ET | 1700 | 3.855 |
| 09:48 ET | 100 | 3.855 |
| 09:50 ET | 3600 | 3.87 |
| 09:51 ET | 7723 | 3.88 |
| 09:53 ET | 100 | 3.88 |
| 09:57 ET | 100 | 3.88 |
| 10:00 ET | 300 | 3.885 |
| 10:02 ET | 300 | 3.895 |
| 10:04 ET | 800 | 3.88 |
| 10:06 ET | 400 | 3.875 |
| 10:09 ET | 200 | 3.88 |
| 10:11 ET | 1235 | 3.875 |
| 10:13 ET | 1200 | 3.87 |
| 10:15 ET | 600 | 3.8794 |
| 10:18 ET | 200 | 3.89 |
| 10:20 ET | 174 | 3.9 |
| 10:22 ET | 600 | 3.91 |
| 10:24 ET | 2500 | 3.905 |
| 10:26 ET | 600 | 3.895 |
| 10:27 ET | 300 | 3.895 |
| 10:29 ET | 300 | 3.9 |
| 10:31 ET | 300 | 3.905 |
| 10:33 ET | 1740 | 3.9 |
| 10:36 ET | 400 | 3.905 |
| 10:38 ET | 3310 | 3.91 |
| 10:40 ET | 1000 | 3.91 |
| 10:42 ET | 500 | 3.895 |
| 10:44 ET | 1466 | 3.895 |
| 10:45 ET | 270 | 3.9 |
| 10:47 ET | 700 | 3.895 |
| 10:49 ET | 200 | 3.9 |
| 10:51 ET | 742 | 3.895 |
| 10:54 ET | 28671 | 3.895 |
| 10:56 ET | 6520 | 3.91 |
| 10:58 ET | 7832 | 3.91 |
| 11:00 ET | 1600 | 3.91 |
| 11:02 ET | 800 | 3.91 |
| 11:03 ET | 200 | 3.91 |
| 11:05 ET | 4028 | 3.91 |
| 11:07 ET | 4253 | 3.9 |
| 11:09 ET | 500 | 3.9 |
| 11:12 ET | 1800 | 3.885 |
| 11:14 ET | 100 | 3.8801 |
| 11:16 ET | 300 | 3.885 |
| 11:18 ET | 400 | 3.885 |
| 11:20 ET | 200 | 3.885 |
| 11:21 ET | 1800 | 3.895 |
| 11:23 ET | 1990 | 3.9 |
| 11:27 ET | 500 | 3.9 |
| 11:30 ET | 100 | 3.9 |
| 11:32 ET | 100 | 3.895 |
| 11:34 ET | 400 | 3.9 |
| 11:36 ET | 700 | 3.9 |
| 11:38 ET | 200 | 3.9 |
| 11:39 ET | 760 | 3.895 |
| 11:41 ET | 1855 | 3.89 |
| 11:43 ET | 300 | 3.895 |
| 11:45 ET | 600 | 3.895 |
| 11:48 ET | 500 | 3.895 |
| 11:50 ET | 200 | 3.89 |
| 11:52 ET | 200 | 3.895 |
| 11:54 ET | 200 | 3.895 |
| 11:56 ET | 100 | 3.89 |
| 11:57 ET | 1900 | 3.89 |
| 11:59 ET | 431 | 3.885 |
| 12:01 ET | 1275 | 3.895 |
| 12:03 ET | 700 | 3.89 |
| 12:06 ET | 700 | 3.895 |
| 12:08 ET | 900 | 3.895 |
| 12:10 ET | 300 | 3.89 |
| 12:12 ET | 300 | 3.895 |
| 12:14 ET | 900 | 3.895 |
| 12:15 ET | 100 | 3.895 |
| 12:17 ET | 6200 | 3.905 |
| 12:19 ET | 100 | 3.9 |
| 12:21 ET | 500 | 3.905 |
| 12:24 ET | 600 | 3.905 |
| 12:26 ET | 1100 | 3.905 |
| 12:28 ET | 1300 | 3.905 |
| 12:30 ET | 800 | 3.905 |
| 12:32 ET | 200 | 3.905 |
| 12:33 ET | 300 | 3.9 |
| 12:35 ET | 3219 | 3.89 |
| 12:37 ET | 7290 | 3.905 |
| 12:39 ET | 3101 | 3.905 |
| 12:42 ET | 7911 | 3.9 |
| 12:44 ET | 9763 | 3.9 |
| 12:46 ET | 614 | 3.9 |
| 12:48 ET | 4860 | 3.905 |
| 12:50 ET | 1764 | 3.905 |
| 12:51 ET | 1200 | 3.905 |
| 12:53 ET | 1000 | 3.9 |
| 12:55 ET | 1921 | 3.905 |
| 12:57 ET | 3300 | 3.905 |
| 01:00 ET | 13082 | 3.9 |
| 01:02 ET | 3690 | 3.91 |
| 01:04 ET | 1300 | 3.905 |
| 01:06 ET | 19894 | 3.9 |
| 01:08 ET | 6618 | 3.9 |
| 01:09 ET | 21992 | 3.89 |
| 01:11 ET | 2371 | 3.895 |
| 01:13 ET | 7128 | 3.895 |
| 01:15 ET | 74962 | 3.9 |
| 01:18 ET | 56214 | 3.9 |
| 01:20 ET | 52270 | 3.9 |
| 01:22 ET | 14235 | 3.895 |
| 01:24 ET | 11704 | 3.895 |
| 01:26 ET | 1080 | 3.895 |
| 01:27 ET | 620 | 3.895 |
| 01:29 ET | 49834 | 3.905 |
| 01:31 ET | 2175 | 3.895 |
| 01:33 ET | 354984 | 3.91 |
| 01:36 ET | 95655 | 3.9051 |
| 01:38 ET | 1457 | 3.905 |
| 01:40 ET | 1750 | 3.905 |
| 01:42 ET | 300 | 3.905 |
| 01:44 ET | 14386 | 3.91 |
| 01:45 ET | 9683 | 3.905 |
| 01:47 ET | 1063 | 3.905 |
| 01:49 ET | 206485 | 3.94 |
| 01:51 ET | 411351 | 3.955 |
| 01:54 ET | 6372 | 3.97 |
| 01:56 ET | 7211 | 3.9748 |
| 01:58 ET | 95216 | 4.005 |
| 02:00 ET | 10837 | 4.0101 |
| 02:02 ET | 20422 | 4.05 |
| 02:03 ET | 9060 | 4.0267 |
| 02:05 ET | 3461 | 4.045 |
| 02:07 ET | 18130 | 4.0512 |
| 02:09 ET | 2900 | 4.045 |
| 02:12 ET | 2161 | 4.06 |
| 02:14 ET | 3200 | 4.065 |
| 02:16 ET | 2539 | 4.07 |
| 02:18 ET | 1114 | 4.0997 |
| 02:20 ET | 5199 | 4.1 |
| 02:21 ET | 15691 | 4.0955 |
| 02:23 ET | 12370 | 4.095 |
| 02:25 ET | 2318 | 4.085 |
| 02:27 ET | 9357 | 4.09 |
| 02:30 ET | 2600 | 4.09 |
| 02:32 ET | 4463 | 4.095 |
| 02:34 ET | 9432 | 4.1 |
| 02:36 ET | 7044 | 4.09 |
| 02:38 ET | 4080 | 4.08 |
| 02:39 ET | 5568 | 4.08 |
| 02:41 ET | 14245 | 4.07 |
| 02:43 ET | 7665 | 4.06 |
| 02:45 ET | 6309 | 4.05 |
| 02:48 ET | 16432 | 4.04 |
| 02:50 ET | 4769 | 4.04 |
| 02:52 ET | 11089 | 4.045 |
| 02:54 ET | 5629 | 4.04 |
| 02:56 ET | 5802 | 4.04 |
| 02:57 ET | 2254 | 4.04 |
| 02:59 ET | 9951 | 4.04 |
| 03:01 ET | 8129 | 4.04 |
| 03:03 ET | 3823 | 4.04 |
| 03:06 ET | 2142 | 4.04 |
| 03:08 ET | 19711 | 4.04 |
| 03:10 ET | 13189 | 4.01 |
| 03:12 ET | 9911 | 4.01 |
| 03:14 ET | 11476 | 4 |
| 03:15 ET | 12822 | 4.01 |
| 03:17 ET | 5788 | 4.015 |
| 03:19 ET | 4520 | 4.02 |
| 03:21 ET | 2397 | 4.025 |
| 03:24 ET | 500 | 4.025 |
| 03:26 ET | 34880 | 4.02 |
| 03:28 ET | 3300 | 4.025 |
| 03:30 ET | 7060 | 4.03 |
| 03:32 ET | 4360 | 4.045 |
| 03:33 ET | 1994 | 4.06 |
| 03:35 ET | 4456 | 4.07 |
| 03:37 ET | 5135 | 4.065 |
| 03:39 ET | 10620 | 4.05 |
| 03:42 ET | 5020 | 4.05 |
| 03:44 ET | 22147 | 4.03 |
| 03:46 ET | 9321 | 4.02 |
| 03:48 ET | 8855 | 4.01 |
| 03:50 ET | 5326 | 4.015 |
| 03:51 ET | 6020 | 4.02 |
| 03:53 ET | 230090 | 4.01 |
| 03:55 ET | 38918 | 4.015 |
| 03:57 ET | 96994 | 4.015 |
| 04:00 ET | 111833 | 4.02 |
Nov 21, 2023
Savara to Present at the Piper Sandler 35(th) Annual Healthcare Conference, from 8:05AM ET on Tuesday Nov 21, 2023 by Dow Jones
8:05AM ET on Tuesday Nov 21, 2023 by Dow Jones
Nov 13, 2023
DJ Savara Price Target Maintained With a $6.00/Share by HC Wainwright & Co., from 11:27AM ET on Monday Nov 13, 2023 by Dow Jones
11:27AM ET on Monday Nov 13, 2023 by Dow Jones
Nov 9, 2023
Savara Reports Third Quarter Financial Results and Provides Business Update, from 4:05PM ET on Thursday Nov 09, 2023 by Dow Jones
4:05PM ET on Thursday Nov 09, 2023 by Dow Jones*DJ Savara 3Q Loss $16.6M >SVRA, from 4:05PM ET on Thursday Nov 09, 2023 by Dow Jones
4:05PM ET on Thursday Nov 09, 2023 by Dow Jones
Nov 8, 2023
Savara to Present at the Jefferies London Healthcare Conference, from 4:05PM ET on Wednesday Nov 08, 2023 by Dow Jones
4:05PM ET on Wednesday Nov 08, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Savara Inc | 526.5M | -12.9x | --- |
bluebird bio Inc | 528.1M | -6.5x | --- |
Icosavax Inc | 511.9M | -4.5x | --- |
ARS Pharmaceuticals Inc | 499.2M | 813.1x | --- |
Oric Pharmaceuticals Inc | 488.2M | -4.6x | --- |
Phathom Pharmaceuticals Inc | 484.9M | -2.2x | --- |
Company Information
Savara Inc. is a clinical-stage biopharmaceutical company. The Company is focused on rare respiratory diseases. The Company’s lead program, molgramostim nebulizer solution (molgramostim), is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is an inhaled formulation of recombinant human GM-CSF and is being developed for the treatment of aPAP. Molgramostim nebulizer solution is administered once daily by inhalation via a high efficiency nebulizer, the eFlow Nebulizer System (PARI Pharma GmbH). Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of surfactant in the alveoli (or air sacs) of the lungs. The Company is engaged in the advancement of the molgramostim aPAP program and the Phase III IMPALA-2 clinical trial, and outsourcing capital-intensive operations.
Contact Information
- Headquarters
- 6836 BEE CAVE ROAD BUILDING 3, SUITE 201AUSTIN, TX, United States 78746
- Phone
- 512-614-1848
- Fax
- 858-552-0876
Executives
- Chairman of the Board, Chief Executive Officer
- Matthew Pauls
- Chief Financial & Administrative Officer, Secretary
- David Lowrance
- Chief Operating Officer
- Robert Lutz
- Chief Medical Officer
- Raymond Pratt
- Lead Independent Director
- Joseph Mccracken
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $526.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 135.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.70 |
EPS | $-0.31 |
Book Value | $0.95 |
P/E Ratio | -12.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
